- 'Sensational' Arsenal back in title race: Arteta
- Survivors count the mental cost of Los Angeles fires
- Arsenal reignite Premier League title charge as Isak stars again
- Thousands across Gaza celebrate ceasefire deal
- Postecoglou slams 'nowhere near good enough' Spurs after Arsenal defeat
- Moyes 'under no illusions' after defeat on Everton return
- Arsenal reignite Premier League title hopes as Isak stars again
- Yamal drives dominant Barca past Betis into Copa del Rey quarters
- Arsenal fightback sinks Spurs to ignite title bid
- Qatar, US announce Gaza truce, hostage release deal
- US consumer inflation rises in December but underlying pressures ease
- McGregor accused of sexual assault in civil suit
- Inter's title defence slowed by draw with spirited Bologna
- Isak fires Newcastle into Premier League top four, Moyes misery
- Sane hits brace as Bayern thump Hoffenheim
- Aston Villa ruin Moyes' Everton return
- Norman replaced as CEO of LIV Golf
- SpaceX delays latest Starship megarocket test to Thursday
- Quake-stricken Vanuatu heads to polls in snap election
- Qatar, US announce Gaza truce, hostage release deal agreed
- Galaxy sign Zanka from Anderlecht
- Police probe abuse of Havertz's wife after Arsenal star's woes
- Drake files defamation suit against Universal over Kendrick Lamar track
- Qatar PM says Gaza truce, hostage release deal agreed
- US firms concerned about Trump tariff, immigration plans: Fed
- Yellen warns against extending Trump's first-term US tax cuts
- Biden hails Gaza deal, says worked with Trump
- US Supreme Court weighs Texas age-check for porn sites
- Brad Pitt isn't messaging you, rep warns, after adoring fan scammed
- Trump's Energy Dept pick wants to develop renewables... and fossil fuels
- Cuba starts freeing prisoners after US terror list deal
- Fire-wrecked Los Angeles waits for winds to drop
- Prince William makes pub visit to meet fellow Aston Villa fans
- Mediators announce Gaza truce, but Israel says some points 'uresolved'
- Van Dijk laughs off talk of Liverpool wobble after more dropped points
- Rubio vows to confront 'dangerous' China, deter Taiwan invasion
- Man City's Premier League title defence is over: Foden
- Society centred around women in UK during Iron Age: scientists
- UK government bans 'zombie drug' xylazine
- Israel, Hamas agree deal for Gaza truce, hostage release: source briefed on talks
- Kosovo raids Serbia-linked offices as tense elections loom
- Social media star Maher says rugby union must do more to grow game
- Upping defence spending 'key point' for NATO summit: ministers
- Russian inflation climbs as Ukraine offensive weighs on economy
- South Africa's Nortje ruled out of Champions Trophy
- US bans controversial red food dye, decades after scientists raised alarm
- Rubio says China cheated its way to power, rejects 'liberal world order'
- US bank profits rise as Wall Street hopes for merger boom
- Methane leaks from Nord Stream pipeline blasts revised up: studies
- Humanity has opened 'Pandora's box of ills,' UN chief warns
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
C.Garcia--AMWN